An interventional study of diagnosis reassessment and Diagnosis strategy and subsequent therapeutic reassessment in Myocardial Ischemia, sponsored by Assistance Publique - Hôpitaux de Paris. Terminated at 1 site in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2016-03-08.
Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Diagnostic
Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment.
in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.
not desired
3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.
This study's enrollment of 260 is above the median of 100 across 1,778 interventional studies indexed under Heart Diseases.
Browse Heart Diseases studies →Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Diagnosis strategy and subsequent therapeutic reassessment All patients are in that arms. They all receive the diagnosis reassessment strategy.
Other: diagnosis reassessment · Other: Diagnosis strategy and subsequent therapeutic reassessment
Strategy of diagnosis reassessment following a decision tree.
Also known as: no other names to specified
Performed by geriatricians, following a decision tree, based on medical history, electrocardiogram, cardiac echotomography and stress scintigraphy
therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly
Time frame: during hospitalization
part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months
Time frame: during hospitalization
This study is terminated, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assistance Publique - Hôpitaux de Paris